Cargando…
Interferon-α2b spray inhalation did not shorten virus shedding time of SARS-CoV-2 in hospitalized patients: a preliminary matched case-control study
Background: Currently, there are no drugs that have been proven to be effective against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Because of its broad antiviral activity, interferon (IFN) should be evaluated as a potential therapeutic agent for treatment of coronavirus disease 20...
Autores principales: | Hao, Shao-rui, Yan, Ren, Zhang, Shan-yan, Lian, Jiang-shan, Cai, Huan, Zhang, Xiao-li, Zheng, Lin, Jia, Hong-yu, Hu, Jian-hua, Yu, Guo-dong, Gu, Jue-qing, Ye, Chan-yuan, Jin, Ci-liang, Lu, Ying-feng, Xin, Jiao-jiao, Sheng, Ji-fang, Yang, Yi-da |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Zhejiang University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7423845/ https://www.ncbi.nlm.nih.gov/pubmed/32748578 http://dx.doi.org/10.1631/jzus.B2000211 |
Ejemplares similares
-
Interferon α-2b spray shortened viral shedding time of SARS-CoV-2 Omicron variant: An open prospective cohort study
por: Xu, Nan, et al.
Publicado: (2022) -
Lopinavir/ritonavir did not shorten the duration of SARS CoV-2 shedding in patients with mild pneumonia in Taiwan
por: Cheng, Chien-Yu, et al.
Publicado: (2020) -
On an Improved Apparatus for Spray Inhalations
por: Adams, James
Publicado: (1879) -
Subcutaneous Emphysema and Pneumomediastinum after Inhaling Pepper Spray
por: Woussen, Sofie, et al.
Publicado: (2016) -
Inhaling muscle spray: A rising trend of abuse
por: Pothiawala, Sohil, et al.
Publicado: (2021)